SCHEMBL13596292

SCHEMBL13596292

CC(C)Nc1ccc(COC(=O)Nc2ccc(COC(=O)Nc3ccc(CC(C)(C)C)cc3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
POLB P06746 1/20 0.44
NAMPT P43490 1/20 0.43
MAPT P10636 3/20 0.41
TP53 P04637 1/20 0.41
LMNA P02545 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KDM1A O60341 2/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ROCK2 O75116 1/20 0.40
RCOR1 Q9UKL0 1/20 0.40
MGLL Q99685 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13596299 1.00 MEN1 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL1753582 0.87 MEN1 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL19901428 0.87 MEN1 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL12848669 0.85 MEN1 (0.51) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL1753752 0.85 MEN1 (0.51) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL12452412 0.83 SMN1; SMN2 (0.49) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL1755636 0.83 KMT2A (0.49) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL13596293 0.80 ESR1 (0.48) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL21788135 0.79 TOP2A (0.51) MEN1KMT2ASMN1; SMN2L3MBTL1LMNA
SCHEMBL1753750 0.77 ROCK2 (0.43) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940784-B2 Water-soluble CC-1065 analogs and their conjugates SYNTARGA B.V. (NL) 2015-01-27 US disclosed
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates Georg-August-Universität Göttingen Stiftung öffentlichen Rechts (ohne Bereich Humanmedizin) (DE) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates PCNA, DCK, BAD MEN1 2080/4885KMT2A 1501/4885SMN1; SMN2 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.